Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice

BACKGROUND: Australian clinical guidelines recommend endocrine therapy for all women with hormone-dependent early breast cancer. Guidelines specify tamoxifen as first-line therapy for pre-menopausal women, and tamoxifen or an aromatase inhibitor (AI) for post-menopausal women depending on the risk o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kemp, Anna, Preen, David B., Saunders, Christobel, Boyle, Frances, Bulsara, Max, Holman, C. D’Arcy J., Malacova, Eva, Roughead, Elizabeth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879327/
https://www.ncbi.nlm.nih.gov/pubmed/24392158
http://dx.doi.org/10.1371/journal.pone.0084835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3879327/
https://www.ncbi.nlm.nih.gov/pubmed/24392158
http://dx.doi.org/10.1371/journal.pone.0084835

Ejemplares similares